Natco Pharma Shares Fall 1% as USFDA Issues 8 Observation
Shares of Natco Pharma tumbled 1% on 20 October after the USFDA (US Food and Drug Administration) issued 8 observations for its Hyderabad unit. The...
Tag : USFDA observations
Cipla Share Fall 2% After US Subsidiary Receives 5 Observations
Cipla shares fell as much as 2% during the trading session on 21 September after InvaGen Pharmaceuticals, its wholly-owned subsidiary, received 5 inspectional observations from...
Aurobindo Pharma Shares Trade 1% Below as Arm Gets One Observation from USFDA
Aurobindo Pharma’s shares were trading in the red after the company’s subsidiary, APL Healthcare Limited, on 20 September received a ‘Form 483’ with one observation...
Solara’s Cuddalore Facility gets a All Clear from USFDA; Shares Rally 2%
Solara Active Pharma Science, Cuddalore facility has been issued Form-483 with zero observation from the USFDA (the United States Food and Drug Administration). The USFDA...
USFDA Finds Regulatory Gaps in Cipla’s Pithampur Facility Inspection: Shares Tumble
Cipla’s Pithampur Manufacturing Facility has received a current Good Manufacturing Practices (cGMP) inspection by the USFDA (the United States Food and Drug Administration) from 6...
Granules Pharma Clears USFDA Inspection; Shares rally 2%
Shares of Granules India rallied up 2% in early trade on August 4 after the company completed an inspection by the USFDA (United States Food...
SEBI Fined Former Wockhardt Executives Rs 13 Lakh for Violating Insider Trading Norms
Market regulator, Securities and Exchange Board of India (SEBI) imposed fines on two former executives of the global pharma company Workhardt totalling Rs 13 lakh...
Gland Pharma Soars 5% On Zero Observation from USFDA
On July 31, Gland Pharma’s share price surged 5.49% to Rs 1,365 after the company acknowledged a zero-observation certificate from the US drug regulator for...
Dr Reddy’s Laboratory Shares Reach 52-Week High, PAI at Srikakulam Unit Concludes With Zero Observation
Shares of Dr Reddy’s Laboratory rose 2% in early trade of July 20 to reach a new 52-week high of Rs 5,360 after the US...
Lupin Receives 6 Observation For Its Pithampur (Indore) Plant
Pharmaceutical major Lupin announced that the drug maker had received six observations from USFDA for its Unit 2 plant in Pithampur, Indore on 26 January....